跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML
Approved
THERAPEUTIC
LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML
Rafarm S.A
🇸🇬 Health Sciences Authority
Approval Date
Dec 15, 2015
Approval ID
de97b22ffc02138c
Company
Rafarm S.A
Type
Therapeutic
Approval Details
Approval Id
de97b22ffc02138c
Drug Name
LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML
Product Name
LAMISOPT PLUS EYE DROPS, SOLUTION 20 MG/ML + 5 MG/ML
Approval Number
SIN14903P
Approval Date
2015-12-15
Registrant
LOTUS INTERNATIONAL PTE. LTD.
Licence Holder
LOTUS INTERNATIONAL PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION
Route Of Administration
OPHTHALMIC
Atc Code
S01ED51
Atc Item Name
timolol, combinations
Pharma Manufacturer Name
LOTUS INTERNATIONAL PTE. LTD.
Company Detail Path
/organization/lotus-international-pte-ltd
Active Ingredients
TIMOLOL MALEATE 6.83 mg/ml EQV TIMOLOL
5 mg/ml
DORZOLAMIDE HYDROCHLORIDE 22.26 mg/ml EQV DORZOLAMIDE
20 mg/ml
DORZOLAMIDE HYDROCHLORIDE 22.26 MG/ML EQV DORZOLAMIDE
20 MG/ML
TIMOLOL MALEATE 6.83 MG/ML EQV TIMOLOL
5 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Dec 15, 2015
Approval ID
de97b22ffc02138c
Type
Therapeutic
Back to HSA Approvals
